2018
DOI: 10.1016/j.clinph.2018.04.614
|View full text |Cite
|
Sign up to set email alerts
|

Implementing Motor Unit Number Index (MUNIX) in a large clinical trial: Real world experience from 27 centres

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

7
46
0
3

Year Published

2018
2018
2021
2021

Publication Types

Select...
6
1

Relationship

3
4

Authors

Journals

citations
Cited by 53 publications
(56 citation statements)
references
References 21 publications
7
46
0
3
Order By: Relevance
“…The twofold higher CMAP amplitudes yielded with an isolectric referential reduces the potential measurement floor effect from too small a CMAP. Previous and ongoing (NCT02611674) studies estimating the motor unit number index (MUNIX) have also used the knee as the referential site, which may improve the utility of this technique as it is not measurable when the CMAP amplitude is below 0.5 mV . Improving the floor effect may also be useful in severe axonal neuropathies when the EDB recording is absent and a response from the TA cannot be measured.…”
Section: Discussionmentioning
confidence: 99%
“…The twofold higher CMAP amplitudes yielded with an isolectric referential reduces the potential measurement floor effect from too small a CMAP. Previous and ongoing (NCT02611674) studies estimating the motor unit number index (MUNIX) have also used the knee as the referential site, which may improve the utility of this technique as it is not measurable when the CMAP amplitude is below 0.5 mV . Improving the floor effect may also be useful in severe axonal neuropathies when the EDB recording is absent and a response from the TA cannot be measured.…”
Section: Discussionmentioning
confidence: 99%
“…To control for the experience-related variations and improve the automation of MUNIX calculation, in this study, the MUNIX repeatability was evaluated by taking into consideration all three previously proposed methods. This explains that the relatively low trial-to-trial CV compared to previously reported results (9,33). In this study, the performance of mMUNIX have been assessed by PCC and CV.…”
Section: Discussionmentioning
confidence: 83%
“…Variations in compound muscle action potential (CMAP) signals and surface EMG contraction signals, and randomness of surface interferential patterns (SIP) selection can affect MUNIX results. Furthermore, suboptimal electrode placement has been suggested as the most recurrent source of errors and systematic mistakes (9). The repeatability of MUNIX has been reported in both healthy and patient subjects, measured by coefficient of variation (CV), interclass correlation coefficients (ICC) and/or correlation coefficients (CC) (8)(9)(10)(11).…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…The multicentre setting of clinical trials provide an ideal environment to evaluate the association between a biomarker and classical clinical endpoints, and to determine its reliability, test-retest validity and site variability (15). Biomarkers should be defined as to their potential utility in all phases of clinical development (e.g.…”
Section: Considerationsmentioning
confidence: 99%